Here, we demonstrated a novel molecular pathway whereby activation of COX4I2 significantly induces fibroblast growth factor 1 (FGF1) expression and thus promotes tumor-associated angiogenesis and the activation of cancer-associated fibroblasts (CAFs). Here, COX4I2 is linked to cancer.